^
BIOMARKER:

18-gene expanded immune signature

News
Twitter
Trials
18-gene expanded immune signature
Gastric Cancer
pembrolizumab
Sensitive: C3 – Early Trials
18-gene expanded immune signature
Head and Neck Cancer
pembrolizumab
Sensitive: C3 – Early Trials